These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28290229)

  • 21. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
    Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
    J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Botulinum Toxin on Masticatory Muscle Pain in Patients with Temporomandibular Disorders: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Kim SR; Chang M; Kim AH; Kim ST
    Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of Botox injections for chronic temporomandibular disorders: do we understand how Botox works on muscle, pain, and the brain?
    Connelly ST; Myung J; Gupta R; Tartaglia GM; Gizdulich A; Yang J; Silva R
    Int J Oral Maxillofac Surg; 2017 Mar; 46(3):322-327. PubMed ID: 27908491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
    Zhang LD; Liu Q; Zou DR; Yu LF
    Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
    Thomas NJ; Aronovich S
    J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
    Mitsikostas DD; Dekundy A; Hanschmann A; Althaus M; Scheschonka A; Pagan F; Jankovic J
    Curr Med Res Opin; 2021 Oct; 37(10):1761-1768. PubMed ID: 34384301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm.
    Chundury RV; Couch SM; Holds JB
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):205-7. PubMed ID: 23552607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study.
    Jog M; Lee J; Scheschonka A; Chen R; Ismail F; Boulias C; Hobson D; King D; Althaus M; Simon O; Dersch H; Frucht S; Simpson DM
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique.
    Guarda-Nardini L; Stecco A; Stecco C; Masiero S; Manfredini D
    Cranio; 2012 Apr; 30(2):95-102. PubMed ID: 22606852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: clinical experience.
    Karacalar A; Yilmaz N; Bilgici A; Baş B; Akan H
    J Craniofac Surg; 2005 May; 16(3):476-81. PubMed ID: 15915120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study on the impact of intra-articular injections of hyaluronic acid, tenoxicam and betametazon on the relief of temporomandibular joint disorder complaints.
    Gencer ZK; Özkiriş M; Okur A; Korkmaz M; Saydam L
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1117-21. PubMed ID: 24853591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of an anesthetic injected into the temporomandibular joint space in patients with TMD.
    Danzig W; May S; McNeill C; Miller A
    J Craniomandib Disord; 1992; 6(4):288-95. PubMed ID: 1298765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of temporomandibular disorders with botulinum toxin.
    Schwartz M; Freund B
    Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis.
    Wissel J; Camões-Barbosa A; Comes G; Althaus M; Scheschonka A; Simpson DM
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of semiconductor laser therapy combined with botulinum toxin A type injection in treatment of temporomandibular disorders].
    Jiang MY; You QL
    Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):758-761. PubMed ID: 28275807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photobiomodulation versus light-emitting diode (LED) therapy in the treatment of temporomandibular disorder: study protocol for a randomized, controlled clinical trial.
    Langella LG; Silva PFC; Costa-Santos L; Gonçalves MLL; Motta LJ; Deana AM; Fernandes KPS; Mesquita-Ferrari RA; Bussadori SK
    Trials; 2018 Jan; 19(1):71. PubMed ID: 29373998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.